Institut Curie

Research facility


Location: Paris, France (FR) FR

ISNI: 0000000406396384

ROR: https://ror.org/04t0gwh46

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Evaluation of Potential Targeted Therapy and Molecular Subtype in Large Nested Variant of Urothelial Carcinoma (LNUC) (2020) Weyerer V, Eckstein M, Comperat E, Juette H, Gaisa N, Allory Y, Stoehr R, et al. Conference contribution Anti-inflammatory activity of superoxide dismutase mimics functionalized with cell-penetrating peptides (2020) Mathieu E, Bernard AS, Ching HY, Somogyi A, Medjoubi K, Fores JR, Bertrand HC, et al. Journal article Liquid Phase Separation Controlled by pH (2020) Adame-Arana O, Weber CA, Zaburdaev V, Prost J, Jülicher F Journal article Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group (2020) Hettmer S, Dachy G, Seitz G, Agaimy A, Duncan C, Jongmans M, Hirsch S, et al. Journal article FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment? (2020) van Rhijn BW, Mertens LS, Mayr R, Bostrom PJ, Real FX, Zwarthoff EC, Boormans JL, et al. Journal article Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol. In press (2020) Kamoun A, de Reyniès A, Allory Y, Sjödahl G, Robertson AG, Seiler R, Hoadley KA, et al. Journal article, Editorial Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma (2019) Jain P, Finger PT, Damato B, Coupland SE, Heimann H, Kenawy N, Brouwer NJ, et al. Journal article PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy (2019) Girard N, Mornex F, Christoph DC, Fietkau R, Filippi AR, Field J, Garrido Lopez P, et al. Conference contribution CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and Prognosis (2019) Masson-Lecomte A, Maille P, Pineda S, Soyeux P, Sagrera A, Rava M, Lopez De Maturana E, et al. Journal article Kalman Inversion Stress Microscopy (2018) Nier V, Peyret G, d'Alessandro J, Ishihara S, Ladoux B, Marcq P Journal article
1 ... 3 4 5 6 7 8